Nuveen »

Monopar Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2025-09-30 $345k 4.2k 81.67

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Nuveen

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Wellington Management Company
Vanguard Group
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics